Sally Ann Frank leads the worldwide HLS strategy, programs and portfolio for Microsoft for Startups, an organization dedicated to accelerating the development of innovative, market-making companies. 

Through business strategy planning, go-to-market development, and technical excellence, she enables startups to achieve their short-term revenue goals and long-term visions. Previously, she was part of Microsoft’s IoT Solutions team, helping healthcare and life sciences companies use IoT to improve patient outcomes and efficiency.  With more than 25 years in the technology industry, she is focused on business outcomes, helping providers, payers, medical device, pharmaceutical and life sciences companies use IoT, Machine Learning, AI and a variety of other Microsoft technologies to meet the changing demands of the healthcare industry. 

She earned an MBA from The George Washington University (Washington, DC), an MS in Systems Management from the University of Southern California and a BS in Marketing and Computer Science from Virginia Tech. Sally is the author of the newly published, The Startup Protocol: A Guide for Digital Health Startups to Bypass Pitfalls and Adopt Strategies that Work, from Routledge Press.

Dr. Greenspun leads Calibre One’s health and well-being practice group, focusing primarily on placing chief medical officers, board positions and similar executives across nearly every industry.

An experienced chief medical officer himself, Greenspun has held executive roles at Deloitte, Dell, Northrop Grumman, Korn Ferry, and Guidehouse. As a cardiac anesthesiologist, Greenspun has practiced in major academic medical centers, as well as community hospitals. He is unique among physician executives, having served every aspect of healthcare and related industries, including payer, provider, life sciences, government, technology, retail, employers & national security.

Co-author of “Reengineering Health Care: A Manifesto for Radically Rethinking Health Care Delivery,” Greenspun is recognized as a thought leader in the healthcare industry and has been named one of the “50 Most Influential Physician Executives in Healthcare” by Modern Healthcare.

Greenspun received his bachelor’s degree from Harvard University, his medical degree from the University of Maryland, and completed his residency and fellowship at the Johns Hopkins University Hospital in anesthesiology and critical care medicine, serving as chief resident. He has served on the advisory boards for the World Economic Forum, Anthem, Healthcare Information and Management Systems Society (HIMSS), Tufts and George Mason universities.

A resident of the D.C. area, Greenspun lives with his wife and sons and enjoys cycling, guitar, and supporting local youth athletic and music programs.

James Hill has over 10 years of experience in venture capital investing in healthcare information technology, financial technology, and enterprise software.

Before joining Grand Ventures, he served as a Vice President of Venture Capital and Private Equity at First Trust Capital Partners. FTCP is the private investment arm of a $200B AUM asset manager with over 90 portfolio companies. During his time there, James led investments in a range of healthcare and fintech investments including Phynd (acquired by symplr), SteadyMD, TouchCare, ClinOne, Dina, ProofPilot, Circuit Clinical, Korio Clinical, and Flexwise.

Prior to First Trust, he was a Vice President at Edison Partners. Edison is a growth-stage venture firm that is on its tenth fund and was primarily focused on fintech, digital health, and enterprise software. While there, James managed the digital health and fintech investment pipelines and led the Edison Director Network. He sourced and helped close more than ten growth-stage investments and served as a board director for multiple healthcare portfolio companies. Some of his investments include Clinverse (acquired by BioClinica), Trialscope (acquired by Informa), Solovis (acquired by Nasdaq), BlueMedora (acquired by VMware), ItemMaster (acquired by Gladson), Predata (acquired by FiscalNote), PurpleLab, Signet Accel, and Virtual Health.

Before his investing career, he had experience working with IBM’s Watson Solutions applying natural language processing to healthcare, financial, and enterprise customer problems, and in law at Bryan Cave, LLP.

James received an MBA in finance and JD focused on corporate law from Michigan State University and holds a BS in History from the University of Wisconsin-Madison.

Dr. Meyers is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org . He helps people get their biomedical ideas to patients by teaching, working with entrepreneurs and leading a global not for profit biomedical and clinical innovation and entrepreneurship network.

He has created several medical devices and digital health companies. Most of them failed. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization.

He teaches at the University of Colorado-Denver, consult, and speak to companies, governments, colleges, and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures.

Dr. Meyers is a former Harvard-Macy fellow and in 2010, he completed a Fulbright Fellowship at Kings Business, the commercialization office of technology transfer at Kings College in London.  Publications include "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap" and "Digital Health Entrepreneurship". He is the Editor-in-Chief of Medscape Reference: Otolaryngology-Head and Neck Surgery. and am a faculty member at the University of Colorado Denver Graduate School, School of Medicine, and Business School where he teaches entrepreneurship.

He has authored many books. blogs and articles and am the editor of the second edition of "Digital Health Entrepreneurship and on Substack at arlenmeyersmdmba.substack.com

Sumit is a serial entrepreneur focused on digital health innovation at scale. He has co-founded and grown five companies over the past three decades that have tackled progressively bolder challenges facing our healthcare economies. All his work features common themes — a big, bold vision that helps us imagine a better world; moonshot technology innovation that disrupts how things have been to create how they can be; complexity designed out of user experiences to blend into people’s daily lives so we can get on with ours; and business models that make such change practical — themes he has honed since the time Sumit worked with Steve Jobs and NeXT in the early 1990s.

Sumit is now Chair and CEO and the founder of Cherish. Cherish develops intelligent radar-based sensor platforms that revolutionize health and safety monitoring wherever people live, work, or play. The company’s patented spatial computing technology works ambiently (through the air) without changing how people live and by prioritizing their privacy. Cherish detects emergencies and health and safety risks to bring people timely help so they and their loved ones may live better with more independence, safety, and peace of mind.

Sumit also serves on the HIMSS board and is Chair of the HIMSS Nominating Committee. He is a lifelong learner and is sought after for his expertise and unstoppable energy as a visionary serial entrepreneur, bold strategist, innovative technologist, and courageous change agent.

Jim Parshall leads electrical and systems engineering R&D for Lilly’s delivery device business. Since joining the pharmaceutical firm in 1999, he has championed disruptive, high-value innovation in various technical and leadership positions across manufacturing, IT, and product development. Assuming his current role in 2022, Jim is currently focused on reducing device development time.

From 2018 to 2022, Jim worked in external innovation, where he identified and evaluated digital health and device partnership opportunities to support Lilly’s therapeutic areas. He also planned and produced the company’s first external innovation challenge and led Lilly to be the founding member of a novel accelerator that helps digital health startups engage with pharma. Prior to that, Jim recognized the healthcare digital disruption, then envisioned and created digital health capabilities at Lilly.

Nick Patel, MD's professional journey encompasses nearly two decades of cutting-edge work in the world of digital healthcare and internal medicine. Serving for 18 years at Prisma Health, Dr. Patel influence was pivotal in many roles, including the inaugural Chief Digital Officer (CDO), Vice Chair of Primary Care in the Department of Medicine in South Carolina.

His tenure as CDO witnessed the ushering in of a new era in healthcare delivery. With a keen eye on the future, Dr. Patel championed the implementation of groundbreaking digital health initiatives, from chatbots and enhanced video consultations to remote patient monitoring and automated campaigns. His visionary approach also saw the introduction of virtual reality and 3D printing in care delivery, underlining his commitment to leveraging technology for better patient outcomes.

While at Prisma, Dr. Patel's strategic insights contributed significantly to the deployment of Prisma’s CRM and the expansion of bedside diabetic retinopathy screening. As a forward-thinking leader, his contributions haven't just been confined to internal projects. He has shared his vast knowledge nationwide, presenting on diverse topics such as digital transformation, AI, telehealth, governance, and health equity.

Today, as the CEO and founder of Stealth Consulting, Dr. Patel is a strategic digital transformation advisor. In this role, he guides health systems, tech companies, and venture capitals towards a digital-first future. His vast experience and innovative thought process have landed him advisory roles in esteemed organizations, including HP Inc., University of South Carolina College of Engineering and Computer Science, and many cutting-edge health-tech firms.

Dr. Patel's commitment to education is evident in his faculty roles at the USC School of Medicine's department of internal medicine and USC School of Engineering and Computing. Notably, as the former Vice Chair of primary care, he spearheaded growth, enhanced provider contracts, and played an instrumental role in redesigning medical practices.

A testament to his expertise, Dr. Patel is one of the two distinguished physicians globally to receive Microsoft’s Most Valuable Professional Award. He is a prolific contributor to Becker’s Hospital Review and is regularly invited to headline webinars. His achievements haven't gone unnoticed; he was honored as one of the Top 20 Chief Digital Officers in 2020 and 2022, and as one of Fierce Healthcare’s 2021 Most Influential Minority Executives. Additionally, Becker’s recognized him as one of the top 50 digital innovators in 2022.